Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weekly (W) herceptin (H) and taxol (T) for metastatic breast cancer (MBC): Correlation of response rate to HER2 immunophenotype (immunohistochemistry (IHC)) and gene amplification (fluorescent in-situ hybridization (FISH))
    Meeting Abstract

    Fornier, M.; Seidman, A. D.; Esteva, F.; Tan, L.; Kaptain, S.; Bach, A.; Arroyo, C. D.; Hortobagyi, G.; Norton, L.; Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Chemotherapy dose, schedule, and the modern treatment of primary breast cancer
    Meeting Abstract

    Norton, L.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save
  • Risk of ipsilateral recurrence (IBTR) and metachronous contralateral breast cancer (CBC) after breast conservation therapy (BCT) in women with germline BRCA1 or BRCA2 mutations
    Meeting Abstract

    Robson, M.; Roberge, D.; Satagopan, J.; Chappuis, P.; Boyd, J.; Offit, K.; Foulkes, W.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save
  • Breast cancer
    Book Section

    McCormick, B.; Hudis, C.; Heerdt, A.; Borgen, P. I.; Dershaw, D. D.; Tan, L. K.; Perez, C. A.; Taylor, M. E.
    In Hoskins, W. J.; Perez, C. A.; Young, R. C. (Eds.) Principles and Practice of Gynecologic Oncology. 3rd ed (2000)

    Fulltext@MSK | Save
  • Development of targeted ansamycins as novel anti-steroid agents and tyrosine kinase inhibitors in the treatment of breast and prostate cancers
    Meeting Abstract

    Zheng, F. F.; Kuduk, S. D.; Munster, P. N.; Chiosis, G.; Sepp-Lorenzino, L.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) inhibits intracellular Akt kinase activity in HER2 overexpressing breast cancer cell lines and enhances the apoptosis induced by cytotoxic agents
    Meeting Abstract

    Munster, P. N.; Basso, A.; Solit, D.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model
    Meeting Abstract

    Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Design and synthesis of small molecule inhibitors of the Hsp90 chaperone
    Meeting Abstract

    Chiosis, G.; Timaul, M. N.; Sepp-Lorenzino, L.; Zheng, F. Z. F.; Lucas, B.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • The presence of a germ-line BRCA mutation is an independent poor prognostic marker in breast cancer: A two-center historical cohort study
    Meeting Abstract

    Foulkes, W. D.; Satagopan, J. M.; Chappuis, P. O.; Wong, N.; Begin, L. R.; Boyd, J.; Offit, K.; Robson, M. E.
    American Journal of Human Genetics (2000)

    Fulltext@MSK | Save